BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Leinco Technologies And CellCarta Partner To Advance Proteomics In Immuno Oncology

Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are ple...

April 21, 2026 | News

Datasea Delivers AI Multimodal Projects Worth RMB 6.9 Million To Accelerate High Margin Shift

Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...

April 21, 2026 | News

Mabwell Secures JFDA GMP Compliance For Denosumab Biosimilars, Marking PIC S Milestone

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-m...

April 21, 2026 | News

Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study

NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...

April 21, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

April 21, 2026 | News

Samsung Bioepis Initiates Phase 1 Clinical Trial for Novel ADC Candidate SBE303 Targeting Nectin 4

Samsung Bioepis Co., Ltd. announced the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody drug conjugate candidate designed...

April 16, 2026 | News

Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, announced positive data from its HT-VA study, conducted unde...

April 15, 2026 | News

Caliway Secures Third Aesthetic Surgery Journal Recognition For CBL 514 Phase 2b Fat Reduction Study

Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the...

April 15, 2026 | News

Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...

April 14, 2026 | News

DualityBio Secures NMPA Review For Trastuzumab Pamirtecan In HER2 Positive Breast Cancer

DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...

April 14, 2026 | News

AnBogen Therapeutics Showcases Imofinostat Breakthroughs At AACR Annual Meeting 2026

AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, announced that two key research abstracts regarding its lead co...

April 14, 2026 | Report

Shanghai Ark Biopharmaceutical Advances First In Human Trial Of Long Acting Influenza Therapy AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...

April 13, 2026 | News

Singlomics Biopharmaceuticals Doses First Patient In Phase I Trial Of DXP 106 Antibody

Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...

April 09, 2026 | News

Alar Pharmaceuticals Reports Positive Phase 1 Results For ALA 3000 In Treatment Resistant Depression

By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, impr...

April 08, 2026 | News

Stay Connected